---
hide:
  - navigation
---

# Academic & Clinical Validation References

To establish a secure, robust, and verifiable bioinformatics validation environment, **quindecagon** incorporates best practices and methodologies recommended by authoritative literature on clinical NGS and medical software validation.

Below is the definitive academic bibliography cited inside the framework:

---

## 1. Recommendations for Bioinformatics in Clinical Practice

- **Citation**: Lavrichenko, K., Engdal, E. S., Marvig, R. L., Jemt, A., Vignes, J. M., Almusa, H., Saether, K. B., Briem, E., Caceres, E., Elvarsdóttir, E. M., Gíslason, M. H., Haanpää, M. K., Henmyr, V., Hotakainen, R., Kaasinen, E., Kanninga, R., Khan, S., Lie-Nielsen, M. G., Madsen, M. B., ... Pruisscher, P. (2024). _Recommendations for bioinformatics in clinical practice_. Cold Spring Harbor Laboratory. [https://doi.org/10.1101/2024.11.23.624993](https://doi.org/10.1101/2024.11.23.624993)
- **Clinical Relevance**: This foundational paper outlines the strict division between research-grade and clinical-grade bioinformatics workflows. It details how clinical diagnostics require robust **Quality Management Systems (QMS)**, complete automation, sample identity verification (to prevent swaps), and deterministic pipeline runs to minimize diagnostic error and protect patient safety.

---

## 2. Best Practice Recommendations for HTS Rare Disease & Cancer Diagnosis

- **Citation**: Ellingford, J. M., Waskiewicz, E., Pritchard, A. J., Lopez, J., Morgan, R., Ley, E., Lyon, M., Sosinsky, A., Kasperaviciute, D., & Ahn, J. W. (2026). _Best practice recommendations for bioinformatics approaches applied to high-throughput sequencing for rare disease and cancer diagnosis within the UK National Health Service_. Journal of Medical Genetics. [https://doi.org/10.1136/jmg-2025-111289](https://doi.org/10.1136/jmg-2025-111289)
- **Clinical Relevance**: Published within the NHS clinical genomics context, this study presents modern guidelines for NGS rare disease and somatic cancer diagnostics. It strongly advocates for:
  - Using Docker containers to enforce software dependency encapsulation and isolation.
  - Using pipeline testing frameworks like `nf-test` to validate updates.
  - Leveraging git version control and rigid reproducibility locks (`nextflow.lock`) to maintain an impenetrable safety boundary.

---

## 3. Biomedical and Clinical Research Data Management

- **Citation**: Ganzinger, M., Glaab, E., Kerssemakers, J., Nahnsen, S., Sax, U., Schaadt, N. S., Schapranow, M.-P., & Tiede, T. (2021). _Biomedical and clinical research data management_. In Systems Medicine (pp. 532–543). Elsevier. [https://doi.org/10.1016/b978-0-12-801238-3.11621-6](https://doi.org/10.1016/b978-0-12-801238-3.11621-6)
- **Clinical Relevance**: This book chapter provides the architectural and data-governance blueprints required for managing highly complex biomedical datasets securely. It serves as our design benchmark for establishing complete security logging, data integrity hashing, and server credential isolation to protect sensitive health profiles.

---

## 4. Cybersecurity Lifecycles and AI Integration

- **Citation**: Vidanagamachchi, S. M., & Waidyarathna, K. M. G. T. R. (2024). _Opportunities, challenges and future perspectives of using bioinformatics and artificial intelligence techniques on tropical disease identification using omics data_. Frontiers in Digital Health, 6. [https://doi.org/10.3389/fdgth.2024.1471200](https://doi.org/10.3389/fdgth.2024.1471200)
- **Clinical Relevance**: This systematic review focuses on data privacy lifecycles inside modern health environments. It details the application of the classic **CIA Triad (Confidentiality, Integrity, Availability)** to high-throughput omics data workflows, emphasizing the need for robust encryption, automated dependency auditing, and multi-layered verification gates to block data exfiltration or injection vulnerabilities.
